ÂÜÀòÂÒÂ×

Xiaoxia Chen is a professional in the pharmaceutical industry with experience in global strategic pricing and contracting. Xiaoxia has held various roles at Novo Nordisk, focusing on developing optimal pricing strategies for the company's assets and portfolio. With a background in business administration, management, and marketing, Xiaoxia has also led projects related to innovative contracting and real-world evidence. Xiaoxia holds an MBA from Tsinghua University and a Master's degree in Marketing from Stockholm School of Economics. Currently, Xiaoxia is pursuing an Executive Master's degree in Evaluation of Health Care Interventions and Outcomes at The London School of Economics and Political Science.